News
Precision medicine company falls into administration
Oncimmune, a precision medicine company, has fallen into administration.
It follows attempts by the business to sell its German trading subsidiary and a failure to...
Mallinckrodt and Endo to combine in $6.7 billion merger
Mallinckrodt and Endo have entered into a definitive agreement to combine in a $6.7 billion deal, after the companies emerged from bankruptcy in connection...
Merck opens $1bn facility to increase vaccine production capacity
Merck (known as MSD outside of the United States and Canada) has opened a new, $1 billion, 225,000 sq ft facility dedicated to vaccine...
